Pereiti prie pagrindinio turinio

Adresas

Panerių g. 246
48454 Kaunas
Lietuva

Darbo laikas

  • Pi – Pe
    9 :00 – 17 00
  • Še  
    Nedirbame    
  • Se
    Nedirbame   
Dog DNA testing illustration

Subacute Necrotizing Encephalopathy (SNE) – Yorkshire Terrier

Kodas: H092

74,72 €

Mėginio duomenys

Vienas tyrimas – vienas mėginys. Gyvūno ir savininko duomenys neprivalomi.

Ieškokite pagal mūsų ar laboratorijos numerį. Nerastas numeris išsaugomas kaip ankstesnis / išorinis numeris. Naujo fizinio mėginio nereikia.
Įdėjimo į krepšelį mygtukas pasirodys po to, kai aukščiau pasirinksite reikšmę

Short description

Subacute Necrotizing Encephalopathy (SNE) in the Yorkshire Terrier is a hereditary neurological disorder caused by an autosomal recessive mutation in the Solute Carrier Family 19 Member 3 (SLC19A3) gene.

General information

Subacute Necrotizing Encephalopathy (SNE) in the Yorkshire Terrier is a hereditary neurological disorder caused by an autosomal recessive mutation in the Solute Carrier Family 19 Member 3 (SLC19A3) gene. This gene is involved in the transport of thiamine (vitamin B1) into cells, which is essential for normal energy metabolism in the brain. When SLC19A3 function is impaired, neuronal cells cannot efficiently utilize energy, leading to progressive neurological dysfunction.

Specifications

Breeds

Yorkshire Terrier

Gene

SLC19A3

Chromosome

25

Mutation

c.205_210delinsN[35]

Organ

Nervous System

Specimen

Swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Autosomal Recessive

Clinical features

Affected dogs typically develop clinical signs in early life, often within the first months to years. Neurological signs may include seizures, ataxia (loss of coordination), behavioral changes, altered mentation, and progressive neurological decline. As the disease progresses, affected dogs may show worsening motor function, difficulty walking, and episodes of collapse. The condition is progressive and can severely impact quality of life, often leading to significant neurological impairment over time.

References

Pubmed ID: 33081289

Year published: 2020

Omia ID: 1097

Omia variant ID:

Turnaround information

  • 10 working days